Ticker: BEAM

Company: Beam Therapeutics Inc.

Person: Giuseppe Ciaramella, officer

Transaction date: April 1, 2026

Reporting date: April 6, 2026

Average share price: 24.58

Sold 11810.0 shares for 290289.8